Dec-2021 Multinational research into clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis

Medihub

Dec-2021 Multinational research into clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis

Speaker: Prof Simon Travis, UK

Last year Ferring organized 2 global advisory board meetings with 11 international experts to understand current thinking and clinical decision making in IBD. In this clip, Prof Simon Travis explains how these meetings have been conducted and the key learnings. The current management approach for mild-to-moderate UC was found to be guided primarily by the patient’s perspectives and goals, alongside assessment of their medical and disease history.

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK